REMEGEN (09995): Purchase financial products
Rongchang Biological (09995) announced that on August 18, 2026, the company further entered into Agreement No. 2 for OCBC Financial Products with OCBC Bank, under which the company agrees to use $30 million of its idle funds to purchase financial products from OCBC Bank.
REMEGEN (09995) announced that on August 18, 2026, the company further entered into Agreement No. 2 for the financial products with OCBC Bank, pursuant to which the company agrees to use USD 30 million of its idle own funds to purchase financial products from OCBC Bank.
Related Articles

SFCE (01165) received the resumption guidance from the Stock Exchange and remains suspended.

BAMA TEA (06980) intends to distribute an interim dividend of 1.2 yuan per share.

Alphabet Inc. Class C (GOOGL.US) teams up with AMD (AMD.US) to create the next generation of AI chips, with Wedbush stating, "The industry may undergo significant changes."
SFCE (01165) received the resumption guidance from the Stock Exchange and remains suspended.

BAMA TEA (06980) intends to distribute an interim dividend of 1.2 yuan per share.

Alphabet Inc. Class C (GOOGL.US) teams up with AMD (AMD.US) to create the next generation of AI chips, with Wedbush stating, "The industry may undergo significant changes."

RECOMMEND





